Market Research data

Immunohistochemistry Market Growth Analysis, Share, Demand By Regions And Forecast To 2027

The global immunohistochemistry market size is expected to reach a value of USD 3.2 billion by 2027, expanding at a CAGR of 7.8%, according to a new report by Radiant Insights, Inc. Rising prevalence of chronic diseases, increasing regulatory approvals, and launch of technologically advanced immunohistochemistry (IHC) systems are expected to propel market growth over the forecast period.

IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs). Thus, a rise in the incidence of these chronic diseases has led to an increase in the demand for IHC techniques. According to 2018 data published by WHO, globally, cancer was one of the leading causes of mortality, and in 2018 around 9.6 million deaths were registered due to cancer. The same source also states that every year CVDs cause around 17.9 million deaths, globally.

Download Free Sample Report @ https://www.radiantinsights.com/research/immunohistochemistry-market/request-sample

Furthermore, increasing regulatory approval and launch of novel IHC products are expected to support IHC market growth. For instance, in May 2019, F. Hoffmann-La Roche AG launched its new VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, intended for the detection of ROS1-positive cancer cases. Additionally, in June 2019, the U.S. FDA approved the expanded use of Agilent Technologies’ PD-L1 IHC 22C3 pharmDx assay for the detection of head and neck squamous cell carcinoma (HNSCC). This product is used in patients receiving treatment with Merck and Co., Inc.’s Keytruda (Pembrolizumab).

However, various limitations associated with immunohistochemistry techniques and the high cost of automated IHC instruments are expected to hinder market growth over the forecast period. Automated immunohistochemistry instruments for disease diagnosis involve high setup costs. As a result, various emerging economies still rely on cost-effective traditional diagnostics that are based on immunostaining of thin tissue sections.

Further key findings from the study suggest:

• Antibodies product segment held the largest market share in 2019 owing to increasing product approval and their high adoption rate, leading to a high demand for IHC techniques

• The diagnostics application segment dominated the IHC market in 2019 and is expected to witness the highest growth over the forecast period due to the rising prevalence of chronic diseases

• Hospitals and diagnostic laboratories dominated the market, by end use in 2019 owing to an increase in the number of hospitals and diagnostic centers with advanced infrastructure and the growing incidence of life-threatening diseases

• North America held the largest market share in 2019 due to the presence of well-established healthcare infrastructure, favorable healthcare reimbursement policies, and the presence of major players in U.S.

• Asia Pacific is anticipated to exhibit fastest growth over the forecast period due to the increasing prevalence of chronic diseases in countries such as China and India

• Some of the key players of immunohistochemistry market are Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd.; Merck KGaA; Danaher Corporation; Perkinelmer, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Bio SB; Agilent Technologies, Inc.; and Abcam plc.

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/immunohistochemistry-market

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Radiant Insights internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Immunohistochemistry (IHC) Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 High prevalence of chronic diseases
3.3.1.2 Intoduction of technollogically advanced IHC solutions
3.3.1.3 Increasing R&D investments
3.3.1.4 Strategic initatives by major players
3.3.1.5 Improving healthcare infrastructure in emerging economies
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of IHC instruments
3.3.2.2 Limitations associated with IHC techniques
3.3.2.3 Increasing Product recalls
3.3.3 Industry challenges
3.3.3.1 Presence of ambiguous regulatory framework

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/healthcare

About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: sales@radiantinsights.com
Website: https://www.radiantinsights.com/

Medical Imaging Market Analysis, Growth, Regional Demand, Industry Technology, New Project Investment And Forecast 2027

The global medical imaging market size is expected to reach USD 28.83 billion by 2027, according to a new report published by Radiant Insights, Inc. It is projected to register a CAGR of 4.0% during the forecast period. Increasing demand for advanced diagnostic systems in developing countries and rising collaborations among market players are the factors driving the growth.

Developing countries have shown a surge in the volume of imaging procedures in the past few years. The low density of installed imaging systems in these regions is expected to provide significant growth potential during the forecast period. Favorable government policies and booming medical tourism in these countries are expected to attract global market players toward untapped markets.

Download Free Sample Report @ https://www.radiantinsights.com/research/medical-imaging-market/request-sample

Integration of multiple imaging modalities is expected to play an important role in market growth. These systems have accurate diagnostic capabilities and are available at affordable prices. The integration of imaging modalities with surgical suites is anticipated to open a new avenue for the medical/diagnostic imaging market at a global level in the forthcoming years.

Development of portable diagnostic tools is important to expand the applications of imaging devices in ambulatory care, clinics, and emergency care departments. Handheld ultrasound devices provide quick and safer images that are critical in emergency care. Ongoing trials and studies to explore the potential of MRI technology for early detection of neurological conditions are showing positive results. The development of new radiofrequency coils is anticipated to expand these applications during the forecast period.

Further key findings from the report suggest:

• Ultrasound captured the largest market share in 2019 and is expected to dominate throughout the forecast period

• Computed tomography is expected to expand at the fastest CAGR during the forecast period

• Rapid technological advancements, such as the development of hybrid imaging modalities and integration of Artificial Intelligence (AI) is anticipated to fuel growth of the CT segment

• Hospital segment is currently dominating the medical imaging market for diagnostic imaging due to blooming healthcare service industry in developing countries

• Ambulatory care centers segment is anticipated to report the fastest growth during the forecast period

• North America captured the largest medical/diagnostic imaging market share in 2019

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/medical-imaging-market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Type by application
1.1.3. End-user
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Radiant Insights internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Type by application outlook
2.2.3. End use outlook
2.2.4. Region outlook
2.3. Competitive Insights

Chapter 3. Diagnostic Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing prevalence of cancer and cardiac diseases
3.4.1.2. Favorable government initiatives
3.4.1.3. Trends of preventive healthcare and disease screening programs
3.4.1.4. Strategic collaborations
3.4.1.5. Technological advancements

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/medical-devices

Nuclear Medicine Market Research Report, Industry Size, Share, Demand, Latest Study, Growth Analysis & Forecast From 2020 To 2027

The global nuclear medicine market size is expected to reach USD 12.6 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Radiant Insights, Inc. Research and development of advanced technologies by the key players for diagnosis and treatment of diseases is expected to drive the radiopharmaceuticals market.

For instance, in May 2019, GE Healthcare with Indi Molecular, Inc., collaborated to develop Protein Catalyzed Capture (PCC) technology and immune cell-targeted PET tracer candidates. This diagnostic tool will help in better understanding of patient’s immune cell and in early treatment response.

Rising prevalence of cancer and cardiovascular diseases is one of the major factors responsible for market growth. Moreover, high prevalence of cancer in emerging Asian countries is creating huge demand for radiopharmaceuticals in diagnosing the disease. For instance, according to the GLOBOCAN, in 2018, approximately 48.4% of cancer cases were registered in Asia.

Download Free Sample Report @ https://www.radiantinsights.com/research/nuclear-medicine-market/request-sample

In addition, presence of standard guidelines prepared by regulatory authorities for radiopharmaceuticals is expected to accelerate market growth. For instance, in August 2019, FDA published a guideline for non-clinical studies and product labelling that are not covered by FDA and ICH guidelines for radiopharmaceuticals used in the treatment of cancer.

Manufacturers are focusing on development of innovative technologies to produce medical isotopes that can fulfill the increasing demand for nuclear medicines. For instance, in October 2018, with the support of ASML, The Institute For Radioelements (IRE) developed and built an electron beamline to manufacture medical isotope molybdenum 99 (Mo-99). Due to this innovative technology, the process of production is waste-free and non-fission.

In addition, research centers and hospitals are launching novel nuclear medicine techniques to treat various diseases at an affordable cost as compared to the existing treatments. For instance, in August 2017, the Kovai Medical Centre and Hospital (KMCH) had launched Rhenium 188 Lipiodol to treat liver cancer and other diseases such as metastatic bone pain, rheumatoid arthritis, and hemophilic bleeding joints at low cost with lesser hospitalization.

Further key findings from the study suggest:

• In 2019, the SPECT segment had dominated the market owing to integration of SPECT with X-ray/CT that has gained more acceptance and proved to be useful in many clinical situations due to its high accuracy

• PET diagnostic nuclear medicine is expected to witness the fastest growth over the forecast period owing to the increasing adoption of high resolution PET scanners

• In case of the therapeutic segment, brachytherapy is anticipated to be the fastest growing segment due to the higher radiation protection as compared to other treatment options

• The oncology application segment dominated the nuclear medicine market in 2019 owing to the presence of pipeline drugs and high prevalence of cancer

• The market in Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and development of radiopharmaceuticals for diagnosis and treatment of various diseases

• Key players in the market include companies such as Eckert and Ziegler Group Nordion, Inc.; Bracco Imaging S.p.A.; and GE Healthcare as well as government organizations such as Department of Atomic Energy and Australian Nuclear Science and Technology Organization (ANSTO).

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/nuclear-medicine-market

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
5.1 Market variable Analysis
5.1.1 Rising incidence of cancer and cardiovascular diseases
5.1.2 Increasing application of radiopharmaceuticals
5.1.3 Growing demand for accurate diagnostic methods
5.1.4 Market Restraint Analysis
5.1.4.1 Stringent regulations pertaining to production, storage, & usage
5.1.4.2 High costs associated with diagnostics & therapeutic procedures

Chapter 6 Business Environment Analysis
6.1.1 SWOT Analysis; By factor (POLITICAL & Legal, economic and technological)
6.1.2 Porter’s five forces analysis
6.1.3 Value chain analysis

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceutical

Aerospace And Defense Materials Market Size, Technology Insights, Trends, Growth, Sales Revenue, Development Status, Top Leaders, And Forecast From 2020 To 2027

The global Aerospace and Defense materials market size is expected to reach USD 28.37 billion by 2027, registering a revenue-based CAGR of 4.0% during the forecast period, according to a new report published by Radiant Insights, Inc. Increasing investment in modernization along with expansion of combat aircraft fleet in countries, such as India and China is expected to drive the growth.

The market is expected to benefit from the strong demand for aircraft in the foreseeable future. The number of commercial and cargo fleets around the world is expected to double over the forecast period. The huge surge in passenger and freight traffic is also anticipated to contribute significantly to the increase in aircraft production and demand for aerospace & defense materials.

Download Free Sample Report @ https://www.radiantinsights.com/research/aerospace-and-defense-materials-market/request-sample

The aerospace & defense industry has been a long-term promoting factor for the development and application of advanced materials. Leading manufacturers are increasingly adopting a variety of advance materials such as carbon fiber composites and titanium alloys. These materials play an important role in reducing the overall weight and increasing fuel efficiency of an aircraft.

The market players often enter into long-term supply contracts with aircraft manufacturers. The material manufacturers provide highly customized solutions to the component and aircraft manufacturer. Aircraft manufacturers are often involved in monitoring the materials throughout the value chain from design to component manufacturing to ensure the quality.

Further key findings from the report suggest:

• Composites is expected to register the highest CAGR of 3.8% in terms of revenue, from 2020 to 2027, owing to the lightweight, high strength, and impact resistance characteristics of the product

• Aerostructure is estimated to be the largest application segment. It accounted for a revenue of USD 10.37 billion in 2019. However, the segment is expected witness a decline in volume due to increased substitution of metals with composites

• Commercial aircraft is estimated to witness substantial growth in terms of revenue at a CAGR of 4.1% from 2020 to 2027, owing to increasing demand from developing economies

• North America held the largest revenue share of the aerospace and defense materials market with 1.8% in 2019, owing to the presence of huge aircraft parts manufacturing industry in the region

• Major market players focus on mergers and acquisitions to expand their business and technological capabilities. They prioritize R&D of low cost materials that provide high strength

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/aerospace-and-defense-materials-market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Radiant Insights Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Snapshot

Chapter 3. Industry Outlook
3.1. Market Segmentation
3.2. Business Segment Trends
3.2.1. Aerospace & Defense Market Analysis
3.2.2. Aerospace & Defense Market: Regional Analysis
3.3. Value Chain Analysis
3.4. Raw Material Trend Analysis
3.4.1. Aluminum
3.4.2. Steel
3.5. Product Price Trend Analysis
3.5.1. Aluminum
3.5.2. Steel
3.6. Market Variable Analysis
3.6.1. Driver
3.6.1.1. Rise in passenger & freight traffic
3.6.1.2. Growing demand for lightweight materials
3.6.2. Restraint
3.6.2.1. Reduced defense expenditure

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/materials

Home Healthcare Market 2020, Growth, Increasing Demand, End User, Regional Trends & Forecast To 2027

The global home healthcare market size is anticipated to reach USD 515.6 billion by 2027, registering a CAGR of 7.9%, according to a new report by Radiant Insights, Inc. This growth can be attributed to cost-efficiency, improved patient outcomes, and convenience offered by home healthcare agencies. In addition, rising geriatric population and growing prevalence of chronic diseases such as Alzheimer’s, dementia, and orthopedic conditions, is expected to drive market growth. As per the Population Reference Bureau data updated in June 2019, the number of people aged 65 years and above was 52 million in 2018 and is projected to double by 2060 to reach 95 million. The World Health Organization (WHO) statistics state that there are around 50 million dementia patients in the world with 10 million new cases getting added every year. This number is expected to reach 82 million by 2030.

Download Free Sample Report @ https://www.radiantinsights.com/research/home-healthcare-market/request-sample

The elderly population is expected to outnumber the children population in the span, which is a demographic shift and poses to be a public health challenge. Besides, maintenance and establishment of hospitals and other healthcare settings need high capital investment. Some of the healthcare solutions providers are following merger and acquisition strategy to enter the market, in order to provide cost-effective service and leverage the expertise of the merged or acquired firm. Also, shifting trends toward in-home healthcare services for patients to avoid hospital stay is another key factor driving home healthcare market growth. In the past several years, the number of nursing facilities has reduced, while the in-home nursing programs have doubled.

Further key findings from the study suggest:

• Services dominated the component segment in 2019 attributed to the growing demand for skilled nurse in-home healthcare for services like physical and occupational therapy

• The rehabilitation services held the largest market share in 2019 and are estimated to expand further during the forecast period. Growing demand for the skilled nurses at home for rehabilitation service, wound dressings, tube feedings, and maintaining stable patient health drive the growth of this segment. Mainly, patients suffering major trauma due to accidents or those suffering from strokes opt for rehabilitation services for improving their way of talking, walking, and feeding themselves all over again

• The clinical management systems dominated the software segment in 2019. This is attributed to its feature to provide all in one solution for home healthcare agencies. The agency software is anticipated to witness high growth during the forecast period

• Key manufacturers operating in the market are Medline Industries, Inc.; McKesson Medical-Surgical Inc.; Medtronic Plc; Baxter International Inc.; Becton, Dickinson And Company; Cardinal Health; and GE Healthcare

• The key service providers are Brookdale Senior Living, Inc.; Home Health Services Ltd.; Sunrise Carlisle, LP; Extendicare, Inc.; Care UK Limited; Senior Care Centers of America; Genesis Healthcare Corp.; Sompo Holdings, Inc.; Kindred Healthcare, Inc.; and Home Instead Senior Care, Inc. The key software solution providers are Allscripts Healthcare Solutions, Inc.; Epic Systems Corporation; Cerner; and McKesson Corporation

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/home-healthcare-market

Table of Contents

Chapter 1 Research Objective
1.1 Objective – 1
1.2 Objective – 2
1.3 Objective – 3
1.4 Objective – 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Component
2.2.2 Region
2.3 Competitive Insights
2.4 Home Healthcare Market Snapshot

Chapter 3 Home Healthcare Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.4 Business Segment Trends
3.4.1 Product business analysis
3.4.2 Regional business analysis
3.5 Penetration and Growth Prospect Mapping
3.5.1 Analysis

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/healthcare

Ambulance Services Market Analysis By Size, Share, Growing Demand, Trends, Companies & Forecast To 2027

The global ambulance services market size is expected to reach USD 50.0 billion by 2027, expanding at a CAGR of 9.3%, according to a new report by Radiant Insights, Inc. Favorable reimbursement policies and rising medical tourisms are anticipated to fuel the demand for ambulance services over the forecast period.

The market is anticipated to grow due to favorable reimbursement policies in developed nations. In U.S., Medicare covers both non-emergency and emergency facilities for medically necessary cases, if the supplier fulfills stipulated requirements. In some circumstances, Medicare also covers unscheduled and irregular nonemergency trips. Medicare covers 80% of the approved amount for ambulance facility and the remaining 20% is covered by supplemental insurance policy of the patient. In New Jersey, Pennsylvania, and South Carolina, for repetitive, nonemergency trips, patients need prior authorization from Medicare Administrative Contractor (MAC). However, Medicare does not pay for ambulettes (wheelchair-accessible vans that provide nonemergency transportation).

Download Free Sample Report @ https://www.radiantinsights.com/research/ambulance-services-market/request-sample

In Victoria, Australia, patients can avail emergency medical assistance by securing a membership with Ambulance Victoria, which offers medical facilities at subsidized prices. Ambulance Tasmania provides free emergency medical assistance to Tasmanian residents. Residents of Queensland (Australia) are covered with the cost of emergency services across Australia, by the QLD state government. Similarly, in U.K., public healthcare system provides free emergency and non-emergency medical facilities. In addition, patients receive NHS funding for their treatment. In Germany, public health insurance (Gesetzliche Krankenversicherung) is compulsory for every citizen and this insurance also covers non-emergency and emergency medical facilities. Private health insurance (Private Krankenversicherung) is usually opted by those who have high yearly income.Ease of payment through reimbursement policies encourages patients to opt for emergency medical assistance more frequently, which is likely to bolster growth of the ambulance services industry.

Further key findings from the study suggest:

• The ground ambulance services segment held the largest market share in 2019 owing to the rising incidence of road accidents across the globe

• Emergency services segment is anticipated to witness the fastest growth over the forecast period owing to the increasing prevalence of cardiovascular diseases such as cardiac arrest, stroke, and congestive heart failure

• The ALS segment is expected to witness rapid growth owing to rising awareness about life support facilities and increase in technologically advanced equipment and trained personnel

• The key players in the ambulance services market include London Ambulance Service NHS Trust; Acadian Ambulance Service; BVG India Limited; Falck A/S; Air Medical Group Holdings Inc.; Air Methods Corporation; and Ziqitza Healthcare Limited.

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/ambulance-services-market

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.2.1 Information procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.5 Region Wise Market Calculation
1.5.1 Region Wise Market: Base Estimates
1.5.2 Global Market: CAGR Calculation
1.6 Region Based Segment Share Calculation
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Market Snapshot

Chapter 3 Ambulance Services Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.3.1 List of regulatory bodies
3.4 Ambulance Services Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Favorable reimbursement policies
3.4.1.2 Entrance of new ambulance service providers globally
3.4.1.3 Rising medical tourism
3.4.1.4 Increasing number of road accidents
3.4.1.5 Rising CVD
3.4.1.6 Increasing geratric population
3.4.2 Market restraint analysis
3.4.2.1 High cost of air ambulances
3.4.2.2 Stringent regulations by the Federal Aviation Administration (FAA)

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/medical-devices

Biomarkers Market Research Report, Industry Size, Share, Demand, Latest Study, Growth Analysis & Forecast From 2020 To 2027

The global biomarkers market size is expected to reach over USD 129.4 billion by 2027, according to a new study conducted by Radiant Insights, Inc. It is anticipated to exhibiting a CAGR of 13.7%, during the forecast period. Factors, such as increasing collaborations and funds for R&D activities, rising consumer awareness, a widening patient base, and technological advancements collectively augmenting market growth.

Download Free Sample Report @ https://www.radiantinsights.com/research/biomarkers-market/request-sample

The drug discovery segment contributed the highest revenue in 2019. Pharmaceutical companies focus on extensive R&D initiatives for the development of targeted therapeutics. Coordinated strategic efforts on biomarker development remain a searing trend among drug manufacturers, academic research institutions, commercial R&D organizations, nonprofitable health foundations, and federal government biomedical regulatory and research agencies.

North America continued to lead the biomarkers market in 2019, driven by an amplifying demand for personalized medicines, high disease prevalence, and proactive government initiatives. It is expected to maintain its lead over the forecast period. Asia Pacific is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.

Some key market players include Abbott; F. Hoffmann-La Roche Ltd.; Qiagen; Siemens Healthcare Private Limited; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Johnson & Johnson Services, Inc; Agilent Technologies, Inc.; and Epigenomics AG. The players are developing novel kits and therapies and drugs to target population in the areas with high unmet clinical needs.

Further key findings from the study suggest:

• Safety biomarkers captured more than 41% market share in 2019, driven by increasing awareness regarding routine healthcare checkups and reduction in drug attrition

• Validation biomarkers is expected to demonstrate the fastest CAGR through to 2027

• Personalized medicine is likely to expand at a CAGR of 14.8% over the forecast period due to consumer awareness and preferences

• Cancer dominated the disease segment in 2019, driven by a high disease burden and presence of a strong pipeline

• Cardiovascular disease segment is projected to witness the fastest growth in the forthcoming years, supported by the growing obese population base and sedentary lifestyles

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/biomarkers-market

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Radiant Insights, Inc. internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biomarkers Market Variables, Trends & Scope
3.1. Biomarkers Market Lineage outlook
3.1.1. Clinical diagnostics market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.3.1. Reimbursement framework
3.3.2. Standards & compliances
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic diseases
3.4.1.2. Technological advancements
3.4.1.3. Funding for biomrkers
3.4.2. Market restraint analysis
3.4.2.1. Reimbursement policies

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/healthcare

Drilling Fluids Market Leading Manufacturers, Consumption, Supply, Demand, Sales & Growth Forecast From 2020 To 2027

The global drilling fluids market size is projected to reach USD 11.1 billion by 2027, according to a new report by Radiant Insights, Inc. The market is projected to witness a moderate CAGR of 4.2% over the forecast period. Revival of new exploration and production projects on account of recovery in oil prices over the next few years is expected to drive the market growth over the forecast period.

Download Free Sample Report @ https://www.radiantinsights.com/research/drilling-fluids-market/request-sample

Ongoing demand for advanced and better formulations for horizontal and directional drilling is expected to provide opportunity to market players. Moreover, the rise in demand for oil and gas has resulted in oil exploration companies exploring unconventional methods of oil extraction.

However, some European countries have established stringent norms for drilling fluids. This is because some drilling fluids, for instance, oil-based fluids, when discharged in water, can form piles of mud and cuttings that cover parts of the seabed which hinders aquatic life. These factors are expected to hinder the growth of the market over the forecast period.

Governments in various countries around the world such as U.S., Indonesia, China, and Australia are taking favorable initiatives to explore untapped oil resources. For instance, the Indonesian government provides favorable trade policies such as 0% import duty on imports of floating or submarine production facilities and drilling platforms, thereby driving the demand for unconventional drilling techniques. Moreover, reduced taxes are applicable over Foreign-owned Drilling Companies (FDCs) carrying out drilling activities in Indonesia, which is another factor driving the demand for drilling fluids.

Further key findings from the report suggest:

• Onshore emerged as the leading application segment of the overall market in 2019 owing to the presence of a large number of onshore oil rigs as compared to offshore oil rigs

• In 2019, North America dominated the global market due to the presence of favorable initiatives taken by the governments in U.S. and Canada for the exploration of oil and gas

• Asia Pacific is expected to register the highest growth rate over the forecast period owing to a rise in oil exploration and production activities in countries such as China, Australia, Brunei, and Indonesia

• The water-based fluids segment dominated the market in 2019 owing to factors such as increase in environmental concerns and cost-effectiveness of these fluids

• Synthetic-based fluids is expected to register a significant growth rate over the forecast period owing to its low toxicity, low bioaccumulation potential, and lower fluid loss when compared to other variants

• Major players in the drilling fluids market include Schlumberger, Baker Hughes, Halliburton, Weatherford International, and National Oilwell Varco. Market players focus on R&D activities and enhancing their product portfolio.

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/drilling-fluids-market

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research methodology
1.2 Research scope & assumptions
1.3 List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, and Scope
3.1 Market segmentation
3.2 Market size and growth prospects
3.3 Drilling fluids value chain analysis
3.4 Raw material trends
3.5 Technological Landscape
3.6 Regulatory Scenario
3.7 Drilling fluids market dynamics
3.7.1 Market driver analysis
3.7.1.1 Rising global hydrocarbon E&P
3.7.1.2 Shift in trend toward developing unconventional resources
3.7.1.3 Increasing offshore production
3.7.2 Market restraint analysis
3.7.2.1 Crude oil price slump
3.7.2.2 Adverse environmental impact of OBF
3.8 Key opportunities – Prioritized
3.9 Industry analysis- Porter’s
3.10 Drilling fluids – PESTEL analysis

Chapter 4 Global Drilling Fluids: Product Outlook
4.1 Global drilling fluids market share by product
4.2 Drilling fluids market estimates and forecast by product, 2016 – 2027 (USD Million)
4.2.1 Oil based fluids (OBF)
4.2.1.1 Market estimates and forecast by region, 2016 – 2027 (USD Million)
4.2.2 Synthetic based fluids (SBF)
4.2.2.1 Market estimates and forecast by region, 2016 – 2027 (USD Million)
4.2.3 Water based fluids (WBF)
4.2.3.1 Market estimates and forecast by region, 2016 – 2027 (USD Million)
4.2.4 Others
4.2.4.1 Market estimates and forecast by region, 2016 – 2027 (USD Million)

Chapter 5 Drilling Fluids: Application Outlook
5.1 Drilling fluids market share by application
5.2 Drilling fluids market estimates and forecast by application, 2016 – 2027 (USD Million)
5.2.1 Onshore
5.2.1.1 Market estimates and forecast in onshore by region, 2016 – 2027 (USD Million)
5.2.2 Offshore
5.2.2.1 Market estimates and forecast in offshore by region, 2016 – 2027 (USD Million)

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/petrochemicals

Biosensors Market Growth Analysis, Share, Demand By Regions, Types And Forecast To 2027

The global biosensors market size is anticipated to reach USD 36.0 billion by 2027, expanding at a CAGR 9%, according to a new report by Radiant Insights, Inc. Various applications in the medical field, high demand for miniature diagnostic devices, and rapid technological advancements are the key driving factors for the market.

Early and precise disease diagnosis is essential for successful prognosis of diseases and survival of patients. In recent years, the demand for simple, disposable, user-friendly, and cost-efficient devices with fast response time has increased extensively leading to increase in the sales of these products, thereby driving the biosensor market.

Download Free Sample Report @ https://www.radiantinsights.com/research/biosensors-market/request-sample

Increase in technological development is expected to be a significant factor for the growth of the market over the forecast period. For instance, in October 2015, Abbott Laboratories launched FreeStyle Libre Glucose Monitoring System in Europe. It is intended to be a replacement for blood glucose meters. Moreover, rising applications of thermal biosensors in biomolecular interaction and hybridization analysis, environmental monitoring, and cosmetic analysis are expected to boost market growth. In addition, the development of nano particle based electrochemical biosensors is expected to create opportunities for the key players, thereby driving the market.

Further key findings from the study suggest:

• On the basis of application, the medical segment dominated the biosensors market in 2019. The device is considered an essential tool in the detection and monitoring of a wide range of medical conditions, such as diabetes and cancer

• Electrochemical biosensors accounted for the largest market share in 2019 and is anticipated to witness a significant growth over the forecast period owing to the widespread applications for quantification and analysis in biochemical and biological processes

• On the basis of end use, biosensors in food industry are expected to witness fastest growth over the forecast period owing to the rising pressure from regulatory bodies pertaining to the hygiene standards of the food items where this device plays a vital role for detecting pathogens, allergens, and pesticides in the food items

• In Asia Pacific, the market is expected to witness the fastest growth over the forecast period, closely followed by Latin America owing to increase in awareness regarding biosensors, and constantly improving healthcare facilities in the region

• Key players in the industry includes AZUR Environmental; Abbott Laboratories; Biosensor BV; Bayer AG; Cranfield Biotechnology Centre; DuPont Biosensor Materials; Ercon, Inc., and Johnson and Johnson.

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/biosensors-market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Information Procurement
1.2.1. Purchased database
1.2.2. Radiant Insights, Inc. internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information Analysis
1.3.1. Data analysis models
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biosensors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User Perspective Analysis
3.4.1. Consumer behaviour analysis
3.4.2. Market influencer analysis
3.5. List of Key End-users, by Region/by Country/by Type
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & compliances

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/medical-devices

Endoscopes Market Leading Manufacturers, Consumption, Analysis & Forecast To 2027

The global endoscopes market size is expected to reach USD 20.4 billion by 2027, according to a new report by Radiant Insights, Inc., registering a CAGR of 8.8% over the forecast period. The market is driven by factors such as increasing geriatric population; growing preference for minimally invasive surgeries; and rise in incidences of cancer, gastrointestinal diseases, and other chronic diseases. The introduction of new technologies in gastrointestinal endoscopy that offers improved visualization and diagnosis, along with high awareness about advanced endoscopes used to perform advanced procedures such as Endoscopic Retrograde Cholangiopancreatography (ERCP), upper gastrointestinal endoscopy, and sigmoidoscopy among medical professionals, also acts as a driving factor for the overall market growth.

Download Free Sample Report @ https://www.radiantinsights.com/research/endoscopes-market/request-sample

Gastrointestinal (GI) endoscopy emerged as the leading application segment in the global market. Growing geriatric population and rising burden of gastrointestinal diseases are among the key factors responsible for rising demand for GI endoscopy. According to a recent study published by the World Health Organization (WHO), the percentage of the global population aged over 60 years is expected to double from about 12% to 22% between 2000 and 2050. In addition, disposable endoscopes are increasingly used owing to technological advancements and launch of new products and the risk of infection associated with conventional reusable endoscopes.

Moreover, endoscopic surgeries require small incisions to diagnose and treat various conditions and are gaining wide acceptance globally. Surgeons prefer robotic surgeries and endoscopic surgeries over conventional open surgeries. Minimally invasive surgeries result in reduced risk of post-operative complications, shorter hospital stay and recovery time, and decreased blood loss during surgeries. These minimally invasive surgeries are an economically viable alternative to open surgeries. Preference for these surgeries has led to an increase in development of capsule endoscopes and robot-assisted endoscopes.

Further key findings from the report suggest:

• Flexible endoscopes emerged as the largest product segment in 2019 with a share of over 50.0% in the global market owing to benefits such as increased safety and efficiency

• Amongst applications,GI endoscopy accounted for the largest share in 2019; however, urology endoscopy is projected to register the highest CAGR over the forecast period

• Hospitals emerged as the leading end-use segment in 2019 and is expected to register a significant growth rate over the forecast period owing to the high number of endoscopic surgeries performed in hospitals

• North America dominated the global endoscopes market in 2019 due to rising geriatric population and increasing demand for minimally invasive surgeries in the region

• Key players operating in the market include Fujifilm Holdings Corporation, Olympus Corporation LLC, Stryker Corporation, Ethicon Endo-Surgery, Richard Wolf GmbH, Karl Storz, and Boston Scientific Corporation

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/endoscopes-market

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 Radiant Insights, Inc.’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Endoscopes Snapshot

Chapter 3 Global Endoscopes Market Variables, Trends, & Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Industry Analysis
3.2.1 User Perspective Analysis
3.2.1.1 Consumer Behavior Analysis
3.2.1.2 Product Specifications
3.2.2 Key End-Users
3.3 Regulatory Framework
3.3.1 Reimbursement Framework
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Asia Pacific
3.3.2 Standards & Compliance
3.3.3 Safety
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.2 Market Restraint Analysis
3.4.3 Industry Challenges

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/medical-devices